8-K: CV Sciences Initiates Arbitration Against Former Legal Counsel Over Tax Withholding Advice

CV Sciences has initiated arbitration against its former legal counsel, Procopio, Cory, Hargreaves & Savitch LLP, alleging damages resulting from reliance on their advice regarding tax withholding for a former CEO's restricted stock units.

Summary

• CV Sciences initiated arbitration against its former legal counsel, Procopio, Cory, Hargreaves & Savitch LLP, on February 12, 2025.
• The dispute centers around legal advice provided by Procopio regarding the tax withholding obligations related to the settlement of restricted stock units (RSUs) previously awarded to former CEO and Board Chair, Michael J. Mona, Jr.
• Procopio initially advised that Mona, as an insider, would not recognize W-2 income until six months after the RSU settlement date due to Section 16(b) of the Securities Exchange Act of 1934.
• Based on this advice, CV Sciences issued Mona shares valued at over $13 million without withholding taxes.
• Procopio later changed its advice, stating that tax withholding was required as of the settlement date.
• CV Sciences disclosed the lack of withholding in its Form 10-Q for the quarter ended March 31, 2019, and subsequent reports, and it has been the subject of multiple legal proceedings.
• Procopio terminated its 12-year relationship with CV Sciences on January 10, 2025, after the company sought to address the legal advice provided.
• CV Sciences seeks to recover damages from Procopio, including fees and expenses paid to Procopio and other professionals, expenses incurred by the company, and other harm.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the legal dispute with the former counsel and the past issues with tax withholding. This creates uncertainty and potential financial burden for the company.

Negatives

• CV Sciences is involved in an arbitration with its former legal counsel, indicating a breakdown in their relationship and potential legal costs.
• The company previously failed to withhold taxes on shares issued to its former CEO, leading to disclosures in SEC filings and multiple legal proceedings.
• The legal dispute with the former CEO was only resolved in November 2024 in the company's favor in a binding arbitration.

Risks

• The outcome of the arbitration is uncertain, and CV Sciences may not be successful in recovering damages from Procopio.
• The legal proceedings could be costly and time-consuming, diverting management's attention from core business operations.
• The dispute could damage the company's reputation and relationships with other legal and professional service providers.
• The company may face further scrutiny from regulatory authorities regarding the tax withholding issue.

Future Outlook

The company will pursue arbitration to recover damages from its former legal counsel.

Industry Context

Legal disputes between companies and their legal counsel are not uncommon, particularly when advice leads to financial or regulatory issues. This case highlights the importance of clear and consistent legal guidance, especially in complex areas like executive compensation and tax compliance.

Comparison to Industry Standards

• It's difficult to compare this specific legal dispute to industry standards without knowing the details of similar cases.
• However, companies like GW Pharmaceuticals (acquired by Jazz Pharmaceuticals) and Canopy Growth Corporation have faced legal and regulatory challenges related to their operations in the cannabis industry, which may provide some context for the types of risks CV Sciences faces.
• Comparing the legal fees and expenses CV Sciences seeks to recover to those incurred by other companies in similar disputes could provide a benchmark for assessing the reasonableness of their claim.

Legal Proceedings

• CV Sciences has initiated arbitration with JAMS against its former legal counsel, Procopio, Cory, Hargreaves & Savitch LLP.
• The company previously resolved a case brought by former CEO Michael J. Mona, Jr. in its favor in a binding arbitration in November 2024.

Stakeholder Impact

• Shareholders may be concerned about the potential costs and risks associated with the legal dispute.
• Employees may experience uncertainty due to the legal issues and potential impact on the company's financial performance.
• Customers and suppliers may be indirectly affected if the legal dispute diverts management's attention or impacts the company's operations.

Next Steps

• CV Sciences will proceed with the arbitration process against Procopio.
• The company will likely need to engage new legal counsel to represent them in the arbitration and other legal matters.

Key Dates